FDA Scientific Capacity Inadequate; New Device Technology At Risk
This article was originally published in The Gray Sheet
Executive Summary
CDRH is not equipped to understand the science behind many cutting-edge device technologies, says a Nov. 29 report from the Subcommittee on Science and Technology, an ad hoc panel of the FDA Science Board